FDA rejects Atara Biotherapeutics' EBVALLO drug application

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NKE
9. USO
10. NVDA

Go back to FDA rejects Atara Biotherapeutics' EBVALLO drug application
(NASDAQ: ATRA) Delayed: 10.51 +0.29 (2.84%)
Previous Close $10.22    52 Week High $40.80 
Open $10.20    52 Week Low $12.45 
Day High $10.71    P/E N/A 
Day Low $10.15    EPS $0.00 
Volume 45,296